News Releases

IBBR Welcomes Dr. Saif Hasan


February 11, 2019 -- IBBR is pleased to extend a warm welcome to Dr. Saif Hasan.  Dr. Hasan joins us as an Assistant Professor in the University of Maryland School of Medicine’s Department of Biochemistry and Molecular Biology. He is a structural biologist who focuses on membrane proteins, and will use IBBR’s new cryo-EM facility to study complexes responsible for biological transport, disease, and virus assembly. 

IBBR Awarded NIH Grant to Investigate T Cell Biology Toward Development of Biotherapeutics


Findings may show how immune checkpoint LAG3 can be exploited to fight disease

(Rockville, MD, January 31, 2019) A team of investigators from the Institute for Bioscience and Biotechnology Research (IBBR) and the University of Pittsburgh recently received a $3.6M National Institutes of Health award to expand the scope of their T cell research involving LAG3 -- a well-known inhibitory receptor on T cells implicated in various cancers, as well as in the chronic infections associated with malaria and HIV.

Congratulations to Dr. Qiong Zhang, Recipient of the UC Berkeley Miller Research Fellowship


January 29, 2019 -- IBBR congratulates Dr. Qiong Zhang as a recipient of the prestigious Miller Research Fellowship, awarded by the Miller Institute for Basic Research in Science at the University of California, Berkeley. Dr. Zhang recently received her Ph.D. in Molecular and Cell Biology from the Biological Sciences Graduate Program (UMCP College of Computer, Mathematical, and Natural Sciences). She worked in the laboratory of IBBR Fellow, Dr. Shunyuan Xiao (Professor, UMCP Department of Plant Science & Landscape Architecture). 

University of Maryland iGEM team, co-advised by IBBR Fellow, Dr. Edward Eisenstein, brings home a gold medal for their innovative plastic waste bioremediation and degradation measurement project


November 30, 2018 -- It takes about 450 years for a plastic bottle to break down in nature, but with the UMD “PETNET” team’s new technology, this time could potentially be cut to as little as 2 weeks.  The team also developed an efficient and economical system to measure degradation.

IBBR Investigator to Lead $3.9M NIH-Funded Project to Develop Next-Generation HIV-1 Immunotherapy Agents


Multi-specific anti-HIV antibodies that neutralize almost all circulating HIV-1 viruses will be optimized to target persistent infection

(Rockville, MD, November 20, 2018) IBBR researchers recently received $3.9 million from the National Institutes of Health (NIH) to develop a multi-specific, single agent antibody therapeutic against HIV-1 to block virus infection and to clear the reservoir of HIV-infected cells from the body. 

IBBR welcomes middle school students for Frontiers in Science & Medicine Day


November 16, 2018 -- Thirty-seven seventh graders from Briggs Chaney and Banneker Middle Schools of Montgomery County visited IBBR, on Friday, November 9, for an especially eye-opening and mind-expanding school day.  The Frontiers in Science and Medicine Day program, a collaborative effort among organizations within the Shady Grove Life Sciences Center, is celebrating its tenth year with nearly 600 students participating program-wide.  IBBR has hosted groups of students for nine years of the Frontiers program.

NIST Director and Standards Alumni Association honor former Associate Director of CARB


October 29, 2018 -- Dr. Gary L. Gilliland was honored on Friday morning, October 26th, with a portrait in the National Institute of Science and Technology (NIST) Portrait Gallery of Distinguished Scientists, Engineers and Administrators.  Dr. Gilliland served as the Associate Director of UMBI CARB, a partnership among the University of Maryland College Park (UMCP), Montgomery County, and NIST, from 1991-1996 and from 2002-2003.  CARB later evolved into the University’s Institute for Bioscience and Biotechnology (IBBR), a partnership among UMCP, University of Maryland Baltimore, and NIST.... Read More

IBBR research discovery could be crucial to development of cross-species Ebola vaccines and treatments


October 16, 2018 -- The recent cases of Ebola virus infection in the Democratic Republic of the Congo are an alarming reminder of the 2014 outbreak in West Africa.  IBBR Fellow Dr. Gilad Ofek, Assistant Professor, University of Maryland, College Park Department of Cell Biology and Molecular Genetics, recently solved the crystal structure of a cross-protective antibody bound to an important ebolavirus surface protein. Structural insights from this work lay important groundwork for the development of vaccines and therapeutics effective across all five species of the virus.

IBBR Receives $1.2M NIH Award to Develop 3D Modeling Tool That Could Lead to New Immunotherapies


New computational tool supports the engineering and development of cancer immunotherapies by predicting how T cell receptors recognize and bind to their targets

(Rockville, MD, October 3, 2018)  The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $1.2M National Institute of Health (NIH) grant to generate a robust modeling and design framework to predict the structures of T cell receptors (TCRs) from sequence, model antigen recognition, and design new TCRs with desired targeting capabilities that can be applied in therapies against... Read More

Harnessing viral enzymes to combat bacterial infections in dairy cows


October 1, 2018 -- When most of us think about viruses and bacteria, we envision germs that make people sick. But, Dr. Daniel Nelson, IBBR Fellow and Associate Professor, Department of Veterinary Medicine at the University of Maryland College Park, studies viruses that may end up making us well -- by killing disease-causing bacteria.